Finance

Beta
Lists
LHC:JSE
Life Healthcare Group Holdings Ltd
ZAC 1,030.00
-0.48%
(-5.00) 1D
Jun 5, 2:16:52 PM GMT+2  ·   ZAC
All symbols
SymbolPriceChange% Change
Generating top insights for LHC...
Open
ZAC 1,025.00
High
ZAC 1,041.00
Low
ZAC 1,025.00
Mkt. cap
15.11B
Avg. vol.
3.04M
Volume
919.55K
Dividend
5.63%
Quarterly dividend
ZAC 14.50
Ex-dividend date
Jun 17, 2026
P/E ratio
2.15
52-wk high
ZAC 1,465.00
52-wk low
ZAC 1,014.00
EPS
ZAC 4.78
Shares outstanding
1.47B
No. of employees
17K
Open
ZAC 1,025.00
High
ZAC 1,041.00
Low
ZAC 1,025.00
Mkt. cap
15.11B
Avg. vol.
3.04M
Volume
919.55K
Dividend
5.63%
Quarterly dividend
ZAC 14.50
Ex-dividend date
Jun 17, 2026
P/E ratio
2.15
52-wk high
ZAC 1,465.00
52-wk low
ZAC 1,014.00
EPS
ZAC 4.78
Shares outstanding
1.47B
No. of employees
17K
News stories
From sources across the web
Profile
Life Healthcare Group is a South African private hospital group, founded in 1983. Headquartered in Johannesburg, the group is focused on Southern Africa, operates 75 main private healthcare facilities, numerous additional clinics and other healthcare facilities, and employs over 16,500 people as of 2025. Wikipedia
About Life Healthcare Group Holdings Ltd
CEOPeter Wharton-Hood
Employees16.5K
Founded1983
Headquarters-
SectorHealth care provider
Last report
May 7, 2026
Fiscal period
Q2 2026
EPS / Est. (ZAR)
- / -
Revenue / Est. (ZAR)
6.28B / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in ZAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ZAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.56B
6.56B
6.28B
6.28B
Cost of goods sold
4.73B
4.73B
4.53B
4.53B
Cost of revenue
4.73B
4.73B
4.53B
4.53B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
615.50M
615.50M
449.50M
449.50M
Operating expense
1.15B
1.15B
1.11B
1.11B
Total operating expenses
5.88B
5.88B
5.64B
5.64B
Operating income
677.00M
677.00M
644.00M
644.00M
Other non operating income
-37.50M
-37.50M
55.50M
55.50M
EBT including unusual items
584.50M
584.50M
549.50M
549.50M
EBT excluding unusual items
663.00M
663.00M
570.00M
570.00M
Income tax expense
208.00M
208.00M
158.50M
158.50M
Effective tax rate
35.59%
35.59%
28.84%
28.84%
Other operating expenses
158.00M
158.00M
245.50M
245.50M
Net income
3.04B
3.04B
385.50M
385.50M
Net profit margin
46.38%
46.38%
6.14%
6.14%
Earnings per share
-
-
-
-
Interest and investment income
50.50M
50.50M
-
-
Interest expense
-91.00M
-91.00M
-132.50M
-132.50M
Net interest expenses
-40.50M
-40.50M
-132.50M
-132.50M
Depreciation and amortization charges
273.00M
273.00M
286.50M
286.50M
EBITDA
849.00M
849.00M
897.75M
897.75M
Gain or loss from assets sale
-27.00M
-27.00M
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more